Literature DB >> 7554027

Reducing the risk of unsafe injections in immunization programmes: financial and operational implications of various injection technologies.

B Aylward1, J Lloyd, M Zaffran, R McNair-Scott, P Evans.   

Abstract

The unsafe use and disposal of injection equipment continues to put patients, health care workers, and the general community at risk of infections such as hepatitis B virus and human immunodeficiency virus. Although the potential for unsafe injection practices varies substantially with the type of equipment that is used, technology alone cannot totally eliminate the risk. A knowledge of the cost, practicality and, most importantly, the potential for misuse, is critical for selecting the most appropriate injection equipment for each immunization setting. Four types of injection equipment are currently available for administering vaccines: sterilizable needles and syringes; standard disposable needles and syringes; autodestruct needles and syringes; and jet injectors. In general, the cost per injection is lowest with sterilizable equipment and highest with autodestruct. However, only autodestruct syringes virtually eliminate the risk of unsafe injection practices. Owing to differences in cost and programme factors, in some settings it may be appropriate to use a combination of equipment. For example, autodestruct syringes may be used in areas where it is difficult to ensure adequate supervision, while in medium-sized, fixed-site clinics with safe injection practices, sterilizable equipment will be the most cost-effective.

Entities:  

Keywords:  Cost Effectiveness; Delivery Of Health Care; Diseases; Equipment And Supplies; Evaluation; Evaluation Indexes; Health; Health Services; Immunization; Infections--prevention and control; Primary Health Care; Quantitative Evaluation; Syringe

Mesh:

Year:  1995        PMID: 7554027      PMCID: PMC2486791     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  16 in total

1.  Large-scale administration of vaccines by means of an automatic jet injection syringe.

Authors:  J WARREN; F A ZIHERL; A W KISH; L A ZIHERL
Journal:  J Am Med Assoc       Date:  1955-02-19

2.  Single-use syringes.

Authors:  M E Samuels; C E Koop; P I Hartsock
Journal:  N Engl J Med       Date:  1991-04-04       Impact factor: 91.245

3.  Self-destructing (non-reusable) syringes.

Authors:  M Marmor; P Hartsock
Journal:  Lancet       Date:  1991-08-17       Impact factor: 79.321

4.  Incidence of intramuscular injections in rural dispensaries in developing countries.

Authors:  F Vincent-Ballereau; C Lafaix; G Haroche
Journal:  Trans R Soc Trop Med Hyg       Date:  1989 Jan-Feb       Impact factor: 2.184

5.  Hazards of injectable therapy.

Authors:  R Soeters; C Aus
Journal:  Trop Doct       Date:  1989-07       Impact factor: 0.731

6.  Risk of virus transmission by jet injection.

Authors:  R Zachoval; F Deinhardt; L Gürtler; J Eisenburg; G Korger
Journal:  Lancet       Date:  1988-01-23       Impact factor: 79.321

Review 7.  Transmission of HIV, hepatitis B virus, and other bloodborne pathogens in health care settings: a review of risk factors and guidelines for prevention. World Health Organization.

Authors:  D J Hu; M A Kane; D L Heymann
Journal:  Bull World Health Organ       Date:  1991       Impact factor: 9.408

8.  The popularity of injections in the Third World: origins and consequences for poliomyelitis.

Authors:  H V Wyatt
Journal:  Soc Sci Med       Date:  1984       Impact factor: 4.634

9.  Risk factors for human immunodeficiency virus seropositivity among children 1-24 months old in Kinshasa, Zaire.

Authors:  J M Mann; H Francis; F Davachi; P Baudoux; T C Quinn; N Nzilambi; N Bosenge; R L Colebunders; P Piot; N Kabote
Journal:  Lancet       Date:  1986-09-20       Impact factor: 79.321

Review 10.  Prevalence of HIV infection among intravenous drug users in the United States.

Authors:  R A Hahn; I M Onorato; T S Jones; J Dougherty
Journal:  JAMA       Date:  1989-05-12       Impact factor: 56.272

View more
  6 in total

1.  Relationship between ADH2 Arg47His variation and hepatocellular carcinoma susceptibility: a meta analysis.

Authors:  Shuzhen Liu; Yongchun Cui; Baohong Yang; Ping Chai; Zheng Su; Qianqian Zhang; Dejie Zheng; Rui Li; Guohua Yu
Journal:  Int J Clin Exp Med       Date:  2015-06-15

Review 2.  Should measles be eradicated?

Authors:  F T Cutts; R Steinglass
Journal:  BMJ       Date:  1998-03-07

3.  Transcutaneous immunization with bacterial ADP-ribosylating exotoxins as antigens and adjuvants.

Authors:  G M Glenn; T Scharton-Kersten; R Vassell; G R Matyas; C R Alving
Journal:  Infect Immun       Date:  1999-03       Impact factor: 3.441

4.  Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile enterotoxin mutant R192G or CpG DNA.

Authors:  S Gerber; C Lane; D M Brown; E Lord; M DiLorenzo; J D Clements; E Rybicki; A L Williamson; R C Rose
Journal:  J Virol       Date:  2001-05       Impact factor: 5.103

5.  Epidemiologic study of chronic hepatitis B virus infection in male volunteer blood donors in Karachi, Pakistan.

Authors:  Saeed Akhtar; Muhammad Younus; Salman Adil; Farrukh Hassan; Sarffraz Hussain Jafri
Journal:  BMC Gastroenterol       Date:  2005-08-08       Impact factor: 3.067

6.  Knowledge and Self-Reported Practice of Insulin Injection Device Disposal among Diabetes Patients in Gondar Town, Ethiopia: A Cross-Sectional Study.

Authors:  Abebe Basazn Mekuria; Begashaw Melaku Gebresillassie; Daniel Asfaw Erku; Kaleab Taye Haile; Eshetie Melese Birru
Journal:  J Diabetes Res       Date:  2016-09-25       Impact factor: 4.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.